The study was small — just 48 adults — and lasted just over two months, so it’s not the final word. But the results add to evidence that GLP-1 drugs like Ozempic might help with cravings for things ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.
The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback